Letter: "Orphan-drug" development - whose responsibility?
D004345:Drug Industry; D009316:National Institutes of Health (U.S.); D004364:Pharmaceutical Preparations; D012106:Research; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations